APO Research

APO RESEARCH · REPORT

Lurasidone Hydrochloride Generics

Selected research

Industry Research

Lurasidone Hydrochloride Generics Industry Research Report 2026

Market perspective

The global Lurasidone Hydrochloride Generics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Lurasidone Hydrochloride Generics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Lurasidone Hydrochloride Generics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Lurasidone Hydrochloride Generics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Lurasidone Hydrochloride Generics include Chia Tai Tianqing Pharmaceutical, Zhejiang Huahai Pharmaceutical, YaoPharma, Yangtze River Pharmaceutical, SJZ No.4 Pharmaceutical, Shandong Jewim Pharmaceutical, Qilu Pharmaceutical, Hansoh Pharma and Hisun Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Lurasidone Hydrochloride Generics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Lurasidone Hydrochloride Generics Market by Company

Chia Tai Tianqing Pharmaceutical

Zhejiang Huahai Pharmaceutical

YaoPharma

Yangtze River Pharmaceutical

SJZ No.4 Pharmaceutical

Shandong Jewim Pharmaceutical

Qilu Pharmaceutical

Hansoh Pharma

Hisun Pharmaceuticals

Cisen Pharmaceutical

Changzhou Pharmaceutical Factory

Zydus

Sun Pharmaceuticals

MSN

Lupin

Dr. Reddy's Laboratories

Amneal

Alkem

Alembic pharmaceuticals

Accord Healthcare

Lurasidone Hydrochloride Generics Segment by Type

20mg per Tablet

40mg per Tablet

60mg per Tablet

80mg per Tablet

120mg per Tablet

Lurasidone Hydrochloride Generics Segment by Application

Schizophrenia

Bipolar Depression

Lurasidone Hydrochloride Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone Hydrochloride Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lurasidone Hydrochloride Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone Hydrochloride Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Lurasidone Hydrochloride Generics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Lurasidone Hydrochloride Generics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Lurasidone Hydrochloride Generics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lurasidone Hydrochloride Generics Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Lurasidone Hydrochloride Generics Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Lurasidone Hydrochloride Generics Sales Market Share by Manufacturers (2021-2026) Table 8. Global Lurasidone Hydrochloride Generics Revenue of Manufacturers (2021-2026) Table 9. Global Lurasidone Hydrochloride Generics Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Lurasidone Hydrochloride Generics Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Lurasidone Hydrochloride Generics Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Lurasidone Hydrochloride Generics, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Lurasidone Hydrochloride Generics, Product Type & Application Table 14. Global Lurasidone Hydrochloride Generics Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Lurasidone Hydrochloride Generics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chia Tai Tianqing Pharmaceutical Company Information Table 19. Chia Tai Tianqing Pharmaceutical Business Overview Table 20. Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 22. Chia Tai Tianqing Pharmaceutical Recent Developments Table 23. Zhejiang Huahai Pharmaceutical Company Information Table 24. Zhejiang Huahai Pharmaceutical Business Overview Table 25. Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 27. Zhejiang Huahai Pharmaceutical Recent Developments Table 28. YaoPharma Company Information Table 29. YaoPharma Business Overview Table 30. YaoPharma Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. YaoPharma Lurasidone Hydrochloride Generics Product Portfolio Table 32. YaoPharma Recent Developments Table 33. Yangtze River Pharmaceutical Company Information Table 34. Yangtze River Pharmaceutical Business Overview Table 35. Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 37. Yangtze River Pharmaceutical Recent Developments Table 38. SJZ No.4 Pharmaceutical Company Information Table 39. SJZ No.4 Pharmaceutical Business Overview Table 40. SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 42. SJZ No.4 Pharmaceutical Recent Developments Table 43. Shandong Jewim Pharmaceutical Company Information Table 44. Shandong Jewim Pharmaceutical Business Overview Table 45. Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 47. Shandong Jewim Pharmaceutical Recent Developments Table 48. Qilu Pharmaceutical Company Information Table 49. Qilu Pharmaceutical Business Overview Table 50. Qilu Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Qilu Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 52. Qilu Pharmaceutical Recent Developments Table 53. Hansoh Pharma Company Information Table 54. Hansoh Pharma Business Overview Table 55. Hansoh Pharma Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Hansoh Pharma Lurasidone Hydrochloride Generics Product Portfolio Table 57. Hansoh Pharma Recent Developments Table 58. Hisun Pharmaceuticals Company Information Table 59. Hisun Pharmaceuticals Business Overview Table 60. Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio Table 62. Hisun Pharmaceuticals Recent Developments Table 63. Cisen Pharmaceutical Company Information Table 64. Cisen Pharmaceutical Business Overview Table 65. Cisen Pharmaceutical Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Cisen Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio Table 67. Cisen Pharmaceutical Recent Developments Table 68. Changzhou Pharmaceutical Factory Company Information Table 69. Changzhou Pharmaceutical Factory Business Overview Table 70. Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Product Portfolio Table 72. Changzhou Pharmaceutical Factory Recent Developments Table 73. Zydus Company Information Table 74. Zydus Business Overview Table 75. Zydus Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zydus Lurasidone Hydrochloride Generics Product Portfolio Table 77. Zydus Recent Developments Table 78. Sun Pharmaceuticals Company Information Table 79. Sun Pharmaceuticals Business Overview Table 80. Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio Table 82. Sun Pharmaceuticals Recent Developments Table 83. MSN Company Information Table 84. MSN Business Overview Table 85. MSN Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. MSN Lurasidone Hydrochloride Generics Product Portfolio Table 87. MSN Recent Developments Table 88. Lupin Company Information Table 89. Lupin Business Overview Table 90. Lupin Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Lupin Lurasidone Hydrochloride Generics Product Portfolio Table 92. Lupin Recent Developments Table 93. Dr. Reddy's Laboratories Company Information Table 94. Dr. Reddy's Laboratories Business Overview Table 95. Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Product Portfolio Table 97. Dr. Reddy's Laboratories Recent Developments Table 98. Amneal Company Information Table 99. Amneal Business Overview Table 100. Amneal Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Amneal Lurasidone Hydrochloride Generics Product Portfolio Table 102. Amneal Recent Developments Table 103. Alkem Company Information Table 104. Alkem Business Overview Table 105. Alkem Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Alkem Lurasidone Hydrochloride Generics Product Portfolio Table 107. Alkem Recent Developments Table 108. Alembic pharmaceuticals Company Information Table 109. Alembic pharmaceuticals Business Overview Table 110. Alembic pharmaceuticals Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Alembic pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio Table 112. Alembic pharmaceuticals Recent Developments Table 113. Accord Healthcare Company Information Table 114. Accord Healthcare Business Overview Table 115. Accord Healthcare Lurasidone Hydrochloride Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Accord Healthcare Lurasidone Hydrochloride Generics Product Portfolio Table 117. Accord Healthcare Recent Developments Table 118. Global Lurasidone Hydrochloride Generics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Lurasidone Hydrochloride Generics Sales by Region (2021-2026) & (K Units) Table 120. Global Lurasidone Hydrochloride Generics Sales Market Share by Region (2021-2026) Table 121. Global Lurasidone Hydrochloride Generics Sales by Region (2027-2032) & (K Units) Table 122. Global Lurasidone Hydrochloride Generics Sales Market Share by Region (2027-2032) Table 123. Global Lurasidone Hydrochloride Generics Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Lurasidone Hydrochloride Generics Revenue Market Share by Region (2021-2026) Table 125. Global Lurasidone Hydrochloride Generics Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Lurasidone Hydrochloride Generics Revenue Market Share by Region (2027-2032) Table 127. North America Lurasidone Hydrochloride Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Lurasidone Hydrochloride Generics Sales by Country (2021-2026) & (K Units) Table 129. North America Lurasidone Hydrochloride Generics Sales by Country (2027-2032) & (K Units) Table 130. North America Lurasidone Hydrochloride Generics Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Lurasidone Hydrochloride Generics Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Lurasidone Hydrochloride Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Lurasidone Hydrochloride Generics Sales by Country (2021-2026) & (K Units) Table 134. Europe Lurasidone Hydrochloride Generics Sales by Country (2027-2032) & (K Units) Table 135. Europe Lurasidone Hydrochloride Generics Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Lurasidone Hydrochloride Generics Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Lurasidone Hydrochloride Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Lurasidone Hydrochloride Generics Sales by Country (2021-2026) & (K Units) Table 139. Asia Pacific Lurasidone Hydrochloride Generics Sales by Country (2027-2032) & (K Units) Table 140. Asia Pacific Lurasidone Hydrochloride Generics Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Lurasidone Hydrochloride Generics Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Lurasidone Hydrochloride Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Lurasidone Hydrochloride Generics Sales by Country (2021-2026) & (K Units) Table 144. South America Lurasidone Hydrochloride Generics Sales by Country (2027-2032) & (K Units) Table 145. South America Lurasidone Hydrochloride Generics Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Lurasidone Hydrochloride Generics Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Lurasidone Hydrochloride Generics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Lurasidone Hydrochloride Generics Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Lurasidone Hydrochloride Generics Sales by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Lurasidone Hydrochloride Generics Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Lurasidone Hydrochloride Generics Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Lurasidone Hydrochloride Generics Sales by Type (2021-2026) & (K Units) Table 153. Global Lurasidone Hydrochloride Generics Sales by Type (2027-2032) & (K Units) Table 154. Global Lurasidone Hydrochloride Generics Sales Market Share by Type (2021-2026) Table 155. Global Lurasidone Hydrochloride Generics Sales Market Share by Type (2027-2032) Table 156. Global Lurasidone Hydrochloride Generics Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Lurasidone Hydrochloride Generics Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Lurasidone Hydrochloride Generics Revenue Market Share by Type (2021-2026) Table 159. Global Lurasidone Hydrochloride Generics Revenue Market Share by Type (2027-2032) Table 160. Global Lurasidone Hydrochloride Generics Price by Type (2021-2026) & (US$/Unit) Table 161. Global Lurasidone Hydrochloride Generics Price by Type (2027-2032) & (US$/Unit) Table 162. Global Lurasidone Hydrochloride Generics Sales by Application (2021-2026) & (K Units) Table 163. Global Lurasidone Hydrochloride Generics Sales by Application (2027-2032) & (K Units) Table 164. Global Lurasidone Hydrochloride Generics Sales Market Share by Application (2021-2026) Table 165. Global Lurasidone Hydrochloride Generics Sales Market Share by Application (2027-2032) Table 166. Global Lurasidone Hydrochloride Generics Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Lurasidone Hydrochloride Generics Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Lurasidone Hydrochloride Generics Revenue Market Share by Application (2021-2026) Table 169. Global Lurasidone Hydrochloride Generics Revenue Market Share by Application (2027-2032) Table 170. Global Lurasidone Hydrochloride Generics Price by Application (2021-2026) & (US$/Unit) Table 171. Global Lurasidone Hydrochloride Generics Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Lurasidone Hydrochloride Generics Distributors List Table 175. Lurasidone Hydrochloride Generics Customers List Table 176. Lurasidone Hydrochloride Generics Industry Trends Table 177. Lurasidone Hydrochloride Generics Industry Drivers Table 178. Lurasidone Hydrochloride Generics Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Lurasidone Hydrochloride Generics Product Image Figure 5. Global Lurasidone Hydrochloride Generics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Lurasidone Hydrochloride Generics Market Size (2021-2032) & (US$ Million) Figure 7. Global Lurasidone Hydrochloride Generics Sales (2021-2032) & (K Units) Figure 8. Global Lurasidone Hydrochloride Generics Average Price (US$/Unit) & (2021-2032) Figure 9. 20mg per Tablet Product Image Figure 10. 40mg per Tablet Product Image Figure 11. 60mg per Tablet Product Image Figure 12. 80mg per Tablet Product Image Figure 13. 120mg per Tablet Product Image Figure 14. Schizophrenia Product Image Figure 15. Bipolar Depression Product Image Figure 16. Global Lurasidone Hydrochloride Generics Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Lurasidone Hydrochloride Generics, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Lurasidone Hydrochloride Generics Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Lurasidone Hydrochloride Generics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Lurasidone Hydrochloride Generics Sales by Region in 2025 Figure 22. Global Lurasidone Hydrochloride Generics Revenue by Region in 2025 Figure 23. North America Lurasidone Hydrochloride Generics Market Size by Country in 2025 Figure 24. North America Lurasidone Hydrochloride Generics Sales Market Share by Country (2021-2032) Figure 25. North America Lurasidone Hydrochloride Generics Revenue Market Share by Country (2021-2032) Figure 26. United States Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Lurasidone Hydrochloride Generics Market Size by Country in 2025 Figure 30. Europe Lurasidone Hydrochloride Generics Sales Market Share by Country (2021-2032) Figure 31. Europe Lurasidone Hydrochloride Generics Revenue Market Share by Country (2021-2032) Figure 32. Germany Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Lurasidone Hydrochloride Generics Market Size by Country in 2025 Figure 43. Asia Pacific Lurasidone Hydrochloride Generics Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Lurasidone Hydrochloride Generics Revenue Market Share by Country (2021-2032) Figure 45. China Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Lurasidone Hydrochloride Generics Market Size by Country in 2025 Figure 54. South America Lurasidone Hydrochloride Generics Sales Market Share by Country (2021-2032) Figure 55. South America Lurasidone Hydrochloride Generics Revenue Market Share by Country (2021-2032) Figure 56. Brazil Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Lurasidone Hydrochloride Generics Market Size by Country in 2025 Figure 60. Middle East and Africa Lurasidone Hydrochloride Generics Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Lurasidone Hydrochloride Generics Revenue Market Share by Country (2021-2032) Figure 62. Egypt Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Lurasidone Hydrochloride Generics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Lurasidone Hydrochloride Generics Sales Market Share by Type (2021-2032) Figure 68. Global Lurasidone Hydrochloride Generics Revenue Market Share by Type (2021-2032) Figure 69. Global Lurasidone Hydrochloride Generics Price (US$/Unit) by Type (2021-2032) Figure 70. Global Lurasidone Hydrochloride Generics Sales Market Share by Application (2021-2032) Figure 71. Global Lurasidone Hydrochloride Generics Revenue Market Share by Application (2021-2032) Figure 72. Global Lurasidone Hydrochloride Generics Price (US$/Unit) by Application (2021-2032) Figure 73. Lurasidone Hydrochloride Generics Value Chain Figure 74. Lurasidone Hydrochloride Generics Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Lurasidone Hydrochloride Generics Industry Opportunities and Challenges

Scope & coverage.

Types
  • 20mg per Tablet
  • 40mg per Tablet
  • 60mg per Tablet
  • 80mg per Tablet
  • 120mg per Tablet
Applications
  • Schizophrenia
  • Bipolar Depression
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
  • YaoPharma
  • Yangtze River Pharmaceutical
  • SJZ No.4 Pharmaceutical
  • Shandong Jewim Pharmaceutical
  • Qilu Pharmaceutical
  • Hansoh Pharma
  • Hisun Pharmaceuticals
  • Cisen Pharmaceutical
  • Changzhou Pharmaceutical Factory
  • Zydus
  • Sun Pharmaceuticals
  • MSN
  • Lupin
  • Dr. Reddy's Laboratories
  • Amneal
  • Alkem
  • Alembic pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Lurasidone Hydrochloride Generics Market Size (2021-2032)
  4. 2.2.2 Global Lurasidone Hydrochloride Generics Sales (2021-2032)
  5. 2.2.3 Global Lurasidone Hydrochloride Generics Market Average Price (2021-2032)
  6. 2.3 Lurasidone Hydrochloride Generics by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 20mg per Tablet
  9. 2.3.3 40mg per Tablet
  10. 2.3.4 60mg per Tablet
  11. 2.3.5 80mg per Tablet
  12. 2.3.6 120mg per Tablet
  13. 2.4 Lurasidone Hydrochloride Generics by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Schizophrenia
  16. 2.4.3 Bipolar Depression
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Lurasidone Hydrochloride Generics Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Lurasidone Hydrochloride Generics Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Lurasidone Hydrochloride Generics Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Lurasidone Hydrochloride Generics Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Lurasidone Hydrochloride Generics Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Lurasidone Hydrochloride Generics, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Lurasidone Hydrochloride Generics, Product Type & Application
  8. 3.8 Global Manufacturers of Lurasidone Hydrochloride Generics, Established Date
  9. 3.9 Global Lurasidone Hydrochloride Generics Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chia Tai Tianqing Pharmaceutical
  2. 4.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 4.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 4.1.3 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  6. 4.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 4.2 Zhejiang Huahai Pharmaceutical
  8. 4.2.1 Zhejiang Huahai Pharmaceutical Company Information
  9. 4.2.2 Zhejiang Huahai Pharmaceutical Business Overview
  10. 4.2.3 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  12. 4.2.5 Zhejiang Huahai Pharmaceutical Recent Developments
  13. 4.3 YaoPharma
  14. 4.3.1 YaoPharma Company Information
  15. 4.3.2 YaoPharma Business Overview
  16. 4.3.3 YaoPharma Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 YaoPharma Lurasidone Hydrochloride Generics Product Portfolio
  18. 4.3.5 YaoPharma Recent Developments
  19. 4.4 Yangtze River Pharmaceutical
  20. 4.4.1 Yangtze River Pharmaceutical Company Information
  21. 4.4.2 Yangtze River Pharmaceutical Business Overview
  22. 4.4.3 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  24. 4.4.5 Yangtze River Pharmaceutical Recent Developments
  25. 4.5 SJZ No.4 Pharmaceutical
  26. 4.5.1 SJZ No.4 Pharmaceutical Company Information
  27. 4.5.2 SJZ No.4 Pharmaceutical Business Overview
  28. 4.5.3 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  30. 4.5.5 SJZ No.4 Pharmaceutical Recent Developments
  31. 4.6 Shandong Jewim Pharmaceutical
  32. 4.6.1 Shandong Jewim Pharmaceutical Company Information
  33. 4.6.2 Shandong Jewim Pharmaceutical Business Overview
  34. 4.6.3 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  36. 4.6.5 Shandong Jewim Pharmaceutical Recent Developments
  37. 4.7 Qilu Pharmaceutical
  38. 4.7.1 Qilu Pharmaceutical Company Information
  39. 4.7.2 Qilu Pharmaceutical Business Overview
  40. 4.7.3 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  42. 4.7.5 Qilu Pharmaceutical Recent Developments
  43. 4.8 Hansoh Pharma
  44. 4.8.1 Hansoh Pharma Company Information
  45. 4.8.2 Hansoh Pharma Business Overview
  46. 4.8.3 Hansoh Pharma Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hansoh Pharma Lurasidone Hydrochloride Generics Product Portfolio
  48. 4.8.5 Hansoh Pharma Recent Developments
  49. 4.9 Hisun Pharmaceuticals
  50. 4.9.1 Hisun Pharmaceuticals Company Information
  51. 4.9.2 Hisun Pharmaceuticals Business Overview
  52. 4.9.3 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
  54. 4.9.5 Hisun Pharmaceuticals Recent Developments
  55. 4.10 Cisen Pharmaceutical
  56. 4.10.1 Cisen Pharmaceutical Company Information
  57. 4.10.2 Cisen Pharmaceutical Business Overview
  58. 4.10.3 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
  60. 4.10.5 Cisen Pharmaceutical Recent Developments
  61. 4.11 Changzhou Pharmaceutical Factory
  62. 4.11.1 Changzhou Pharmaceutical Factory Company Information
  63. 4.11.2 Changzhou Pharmaceutical Factory Business Overview
  64. 4.11.3 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Product Portfolio
  66. 4.11.5 Changzhou Pharmaceutical Factory Recent Developments
  67. 4.12 Zydus
  68. 4.12.1 Zydus Company Information
  69. 4.12.2 Zydus Business Overview
  70. 4.12.3 Zydus Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Zydus Lurasidone Hydrochloride Generics Product Portfolio
  72. 4.12.5 Zydus Recent Developments
  73. 4.13 Sun Pharmaceuticals
  74. 4.13.1 Sun Pharmaceuticals Company Information
  75. 4.13.2 Sun Pharmaceuticals Business Overview
  76. 4.13.3 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
  78. 4.13.5 Sun Pharmaceuticals Recent Developments
  79. 4.14 MSN
  80. 4.14.1 MSN Company Information
  81. 4.14.2 MSN Business Overview
  82. 4.14.3 MSN Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 MSN Lurasidone Hydrochloride Generics Product Portfolio
  84. 4.14.5 MSN Recent Developments
  85. 4.15 Lupin
  86. 4.15.1 Lupin Company Information
  87. 4.15.2 Lupin Business Overview
  88. 4.15.3 Lupin Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Lupin Lurasidone Hydrochloride Generics Product Portfolio
  90. 4.15.5 Lupin Recent Developments
  91. 4.16 Dr. Reddy's Laboratories
  92. 4.16.1 Dr. Reddy's Laboratories Company Information
  93. 4.16.2 Dr. Reddy's Laboratories Business Overview
  94. 4.16.3 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Product Portfolio
  96. 4.16.5 Dr. Reddy's Laboratories Recent Developments
  97. 4.17 Amneal
  98. 4.17.1 Amneal Company Information
  99. 4.17.2 Amneal Business Overview
  100. 4.17.3 Amneal Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Amneal Lurasidone Hydrochloride Generics Product Portfolio
  102. 4.17.5 Amneal Recent Developments
  103. 4.18 Alkem
  104. 4.18.1 Alkem Company Information
  105. 4.18.2 Alkem Business Overview
  106. 4.18.3 Alkem Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Alkem Lurasidone Hydrochloride Generics Product Portfolio
  108. 4.18.5 Alkem Recent Developments
  109. 4.19 Alembic pharmaceuticals
  110. 4.19.1 Alembic pharmaceuticals Company Information
  111. 4.19.2 Alembic pharmaceuticals Business Overview
  112. 4.19.3 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
  114. 4.19.5 Alembic pharmaceuticals Recent Developments
  115. 4.20 Accord Healthcare
  116. 4.20.1 Accord Healthcare Company Information
  117. 4.20.2 Accord Healthcare Business Overview
  118. 4.20.3 Accord Healthcare Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Accord Healthcare Lurasidone Hydrochloride Generics Product Portfolio
  120. 4.20.5 Accord Healthcare Recent Developments
5 Global Lurasidone Hydrochloride Generics Market Scenario by Region
  1. 5.1 Global Lurasidone Hydrochloride Generics Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Lurasidone Hydrochloride Generics Sales by Region: 2021-2032
  3. 5.2.1 Global Lurasidone Hydrochloride Generics Sales by Region: 2021-2026
  4. 5.2.2 Global Lurasidone Hydrochloride Generics Sales by Region: 2027-2032
  5. 5.3 Global Lurasidone Hydrochloride Generics Revenue by Region: 2021-2032
  6. 5.3.1 Global Lurasidone Hydrochloride Generics Revenue by Region: 2021-2026
  7. 5.3.2 Global Lurasidone Hydrochloride Generics Revenue by Region: 2027-2032
  8. 5.4 North America Lurasidone Hydrochloride Generics Market Facts & Figures by Country
  9. 5.4.1 North America Lurasidone Hydrochloride Generics Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Lurasidone Hydrochloride Generics Sales by Country (2021-2032)
  11. 5.4.3 North America Lurasidone Hydrochloride Generics Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Lurasidone Hydrochloride Generics Market Facts & Figures by Country
  16. 5.5.1 Europe Lurasidone Hydrochloride Generics Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Lurasidone Hydrochloride Generics Sales by Country (2021-2032)
  18. 5.5.3 Europe Lurasidone Hydrochloride Generics Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Lurasidone Hydrochloride Generics Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Lurasidone Hydrochloride Generics Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Lurasidone Hydrochloride Generics Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Lurasidone Hydrochloride Generics Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Lurasidone Hydrochloride Generics Market Facts & Figures by Country
  41. 5.7.1 South America Lurasidone Hydrochloride Generics Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Lurasidone Hydrochloride Generics Sales by Country (2021-2032)
  43. 5.7.3 South America Lurasidone Hydrochloride Generics Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Lurasidone Hydrochloride Generics Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Lurasidone Hydrochloride Generics Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Lurasidone Hydrochloride Generics Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Lurasidone Hydrochloride Generics Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Lurasidone Hydrochloride Generics Sales by Type (2021-2032)
  2. 6.1.1 Global Lurasidone Hydrochloride Generics Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Lurasidone Hydrochloride Generics Sales Market Share by Type (2021-2032)
  4. 6.2 Global Lurasidone Hydrochloride Generics Revenue by Type (2021-2032)
  5. 6.2.1 Global Lurasidone Hydrochloride Generics Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Lurasidone Hydrochloride Generics Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Lurasidone Hydrochloride Generics Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Lurasidone Hydrochloride Generics Sales by Application (2021-2032)
  2. 7.1.1 Global Lurasidone Hydrochloride Generics Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Lurasidone Hydrochloride Generics Sales Market Share by Application (2021-2032)
  4. 7.2 Global Lurasidone Hydrochloride Generics Revenue by Application (2021-2032)
  5. 7.2.1 Global Lurasidone Hydrochloride Generics Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Lurasidone Hydrochloride Generics Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Lurasidone Hydrochloride Generics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Lurasidone Hydrochloride Generics Value Chain Analysis
  2. 8.1.1 Lurasidone Hydrochloride Generics Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Lurasidone Hydrochloride Generics Production Mode & Process
  5. 8.2 Lurasidone Hydrochloride Generics Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Lurasidone Hydrochloride Generics Distributors
  8. 8.2.3 Lurasidone Hydrochloride Generics Customers
9 Global Lurasidone Hydrochloride Generics Analyzing Market Dynamics
  1. 9.1 Lurasidone Hydrochloride Generics Industry Trends
  2. 9.2 Lurasidone Hydrochloride Generics Industry Drivers
  3. 9.3 Lurasidone Hydrochloride Generics Industry Opportunities and Challenges
  4. 9.4 Lurasidone Hydrochloride Generics Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research